234 related articles for article (PubMed ID: 29220871)
1. Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.
Corrente F; Bellesi S; Metafuni E; Puggioni PL; Marietti S; Ciminello AM; Za T; Sorà F; Fianchi L; Sica S; De Stefano V; Chiusolo P
Cytometry B Clin Cytom; 2018 May; 94(3):468-476. PubMed ID: 29220871
[TBL] [Abstract][Full Text] [Related]
2. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
[TBL] [Abstract][Full Text] [Related]
3. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement.
Owaidah TM; Rawas FI; Al Khayatt MF; Elkum NB
Hematol Oncol Stem Cell Ther; 2008; 1(1):34-7. PubMed ID: 20063526
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].
Li JL; Liu YR; Qin YZ; Chang Y; Fu JY; Wang H; Ruan GR; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):142-5. PubMed ID: 12744735
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR-ABL1, KMT2A rearrangement, and other adult B-cell precursor acute lymphoblastic leukemia.
Wang YZ; Qin YZ; Chang Y; Yuan XY; Chen WM; He LL; Hao L; Shi WH; Jiang Q; Jiang H; Huang XJ; Liu YR
Cytometry B Clin Cytom; 2022 Sep; 102(5):360-369. PubMed ID: 35735203
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
[TBL] [Abstract][Full Text] [Related]
9. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
11. Atypical BCR-ABL1 fusion transcripts in adult B-acute lymphoblastic leukemia, including a novel fusion transcript-e8a1.
Deshpande PA; Srivastava VM; Mani S; Anandhan S; Meena J; Abraham A; Viswabandya A; George B; Srivastava A; Mathews V; Balasubramanian P
Leuk Lymphoma; 2016 Oct; 57(10):2481-4. PubMed ID: 26942999
[No Abstract] [Full Text] [Related]
12. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
[TBL] [Abstract][Full Text] [Related]
13. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion.
Tabernero MD; Bortoluci AM; Alaejos I; López-Berges MC; Rasillo A; García-Sanz R; García M; Sayagués JM; González M; Mateo G; San Miguel JF; Orfao A
Leukemia; 2001 Mar; 15(3):406-14. PubMed ID: 11237064
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council.
Paietta E; Racevskis J; Neuberg D; Rowe JM; Goldstone AH; Wiernik PH
Leukemia; 1997 Nov; 11(11):1887-90. PubMed ID: 9369422
[TBL] [Abstract][Full Text] [Related]
15. [Mutations in the BCR-ABL1 gene in a peruvian patient with acute lymphoblastic leukemia resistant to therapy].
Ortiz CA; Alvarez YP; Dongo-Pflucker KL; Valdivia E; Mendoza Fernández J; Dávila S; Mora-Alférez P
Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):162-166. PubMed ID: 28657534
[TBL] [Abstract][Full Text] [Related]
16. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.
Sánchez R; Ribera J; Morgades M; Ayala R; Onecha E; Ruiz-Heredia Y; Juárez-Rufián A; de Nicolás R; Sánchez-Pina J; Vives S; Zamora L; Mercadal S; Coll R; Cervera M; García O; Ribera JM; Martínez-López J
Blood Cancer J; 2020 Apr; 10(4):43. PubMed ID: 32332702
[TBL] [Abstract][Full Text] [Related]
17. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
Westbrook CA; Hooberman AL; Spino C; Dodge RK; Larson RA; Davey F; Wurster-Hill DH; Sobol RE; Schiffer C; Bloomfield CD
Blood; 1992 Dec; 80(12):2983-90. PubMed ID: 1467514
[TBL] [Abstract][Full Text] [Related]
19. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
20. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]